购物车
- 全部删除
- 您的购物车当前为空
Reversan是一种对多药耐药相关蛋白(MRP1)和P -糖蛋白(Pgp)作用的小分子抑制剂,在胶质母细胞瘤等抗肿瘤研究中被发现可以改善化疗效果,具有高效和无毒的优点。
为众多的药物研发团队赋能,
让新药发现更简单!
Reversan是一种对多药耐药相关蛋白(MRP1)和P -糖蛋白(Pgp)作用的小分子抑制剂,在胶质母细胞瘤等抗肿瘤研究中被发现可以改善化疗效果,具有高效和无毒的优点。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,350 | 现货 | |
5 mg | ¥ 3,390 | 现货 | |
10 mg | ¥ 4,930 | 现货 | |
25 mg | ¥ 10,900 | 现货 | |
50 mg | ¥ 19,800 | 现货 |
产品描述 | Reversan(CBLC4H10), a small molecule inhibitor that acts on multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (Pgp), has been found to improve the efficacy of chemotherapy for glioblastoma, with the advantages of being highly effective and non-toxic. |
别名 | CBLC4H10, CBLC 4H10 |
分子量 | 441.53 |
分子式 | C26H27N5O2 |
CAS No. | 313397-13-6 |
Smiles | O=C(NCCCN1CCOCC1)C=2C=NN3C2N=C(C=C3C=4C=CC=CC4)C=5C=CC=CC5 |
密度 | 1.26 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 10 mg/mL (22.65 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
评论内容